{"id":499379,"date":"2021-05-27T08:04:57","date_gmt":"2021-05-27T12:04:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/"},"modified":"2021-05-27T08:04:57","modified_gmt":"2021-05-27T12:04:57","slug":"i-mab-announces-upcoming-participation-at-june-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/","title":{"rendered":"I-Mab Announces Upcoming Participation at June Conferences"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SHANGHAI<\/span> and <span class=\"xn-location\">GAITHERSBURG, Md.<\/span>, <span class=\"xn-chron\">May 27, 2021<\/span> \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in June. Details of the conferences and management presentation are as follows:<\/p>\n<p>\n        <b>Jefferies Healthcare Conference (Virtual)<br \/><\/b>Fireside chat: Tuesday, June\u00a01, 2021 at <span class=\"xn-chron\">3:00 p.m.ET<\/span><br \/>Speaker: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman and Director<\/p>\n<p>Webcast link: <a target=\"_blank\" href=\"https:\/\/wsw.com\/webcast\/jeff174\/imab\/1821663\" rel=\"nofollow noopener\">https:\/\/wsw.com\/webcast\/jeff174\/imab\/1821663<\/a>. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at <a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener\">http:\/\/ir.i-mabbiopharma.com\/<\/a>.<\/p>\n<p>One-on-one meetings: June\u00a02-4, 2021<br \/>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>For more information, please contact your Jefferies representative. <\/p>\n<p>\n        <b>Huatai Securities 2021 Interim Investment Strategy Conference<br \/><\/b>Management participant: Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">June 2-3, 2021<\/span><br \/>Location: InterContinental Global Center, <span class=\"xn-location\">Chengdu<\/span><\/p>\n<p>For more information, please contact your Huatai representative.<\/p>\n<p>\n        <b>Credit Suisse Asia Healthcare Corporate Day (Virtual)<br \/><\/b>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">June 7-10, 2021<\/span><\/p>\n<p>For more information, please contact your Credit Suisse representative.<\/p>\n<p>\n        <b>BofA 2021 Innovative China Conference (Virtual)<br \/><\/b>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>One-on-one and small group meetings: June\u00a011, 2021<\/p>\n<p>For more information, please contact your BofA\u00a0representative. <\/p>\n<p>\n        <b>Haitong Annual Investor Conference \u2013 Innovative Medicine CEO Forum<br \/><\/b>Keynote Presentation: Wednesday, June\u00a016, 2021 at <span class=\"xn-chron\">10:00 a.m.<\/span> China Time<br \/>Presenter: Dr. Joan Huaqiong Shen, Director and Chief Executive Officer<br \/>Location: Shangri-La Hotel, <span class=\"xn-location\">Shanghai<\/span><\/p>\n<p>Small group meetings: June\u00a016, 2021<br \/>Management participant: Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>For more information, please contact your Haitong representative. <\/p>\n<p>\n        <b>Goldman Sachs Hybrid Healthcare Corporate Day (Virtual)<br \/><\/b>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Executive Director Investor Relations<\/p>\n<p>One-on-one and small group meetings: June\u00a022-24, 2021<\/p>\n<p>For more information, please contact your Goldman Sachs representative. <\/p>\n<p>\n        <b>About I-Mab<\/b>\n      <\/p>\n<p>I-Mab (Nasdaq: IMAB) is an innovation-driven global biotech company focusing on discovery, development and soon commercialization of novel and highly differentiated biologics in immuno-oncology therapeutic area. The Company&#8217;s mission is to bring transformational medicines to patients around the world through drug innovation. I-Mab&#8217;s globally competitive pipeline of more than 15 clinical and pre-clinical stage drug candidates is driven by its internal R&amp;D capability and global licensing partnerships, based on the Company&#8217;s unique Fast-to-Proof-of-Concept and Fast-to-Market pipeline development strategies. The Company is now rapidly progressing from a clinical stage biotech company to a fully integrated global biopharmaceutical company with cutting-edge global R&amp;D capabilities, a world-class GMP manufacturing facility and commercialization capability. I-Mab has established its global footprint in <span class=\"xn-location\">Shanghai<\/span> (headquarters), <span class=\"xn-location\">Beijing<\/span>, <span class=\"xn-location\">Hangzhou<\/span> and <span class=\"xn-location\">Hong Kong<\/span> in <span class=\"xn-location\">China<\/span>, and <span class=\"xn-location\">Maryland<\/span> and <span class=\"xn-location\">San Diego<\/span> in <span class=\"xn-location\">the United States<\/span>. For more information, please visit\u00a0<a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener\">http:\/\/ir.i-mabbiopharma.com<\/a>\u00a0and follow I-Mab on\u00a0<a target=\"_blank\" href=\"https:\/\/www.linkedin.com\/company\/i-mab\/\" rel=\"nofollow noopener\">LinkedIn<\/a>,\u00a0<a target=\"_blank\" href=\"https:\/\/twitter.com\/IMabBiopharma\" rel=\"nofollow noopener\">Twitter<\/a>\u00a0and\u00a0<a target=\"_blank\" href=\"https:\/\/mp.weixin.qq.com\/s\/_s634aizyQPuq1Vgf-hLGA\" rel=\"nofollow noopener\">WeChat<\/a>.<\/p>\n<p>\n        <b>For more information, please contact:<\/b>\n      <\/p>\n<p>\n        <b>I-Mab<\/b>\n      <\/p>\n<p>Jielun Zhu, Chief Financial Officer<br \/>E-mail:\u00a0<a target=\"_blank\" href=\"mailto:jielun.zhu@i-mabbiopharma.com\" rel=\"nofollow noopener\">jielun.zhu@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 8000<\/p>\n<p>\n        <span class=\"xn-person\">Gigi Feng<\/span>, Chief Communications Officer<br \/>E-mail:\u00a0<a target=\"_blank\" href=\"mailto:gigi.feng@i-mabbiopharma.com\" rel=\"nofollow noopener\">gigi.feng@i-mabbiopharma.com<\/a><br \/>Office line: +86 21 6057 5785<\/p>\n<p>\n        <b>Investor Inquiries:<\/b>\n      <\/p>\n<p>\n        <i>The Piacente Group, Inc.<br \/><\/i><br \/>\n        <span class=\"xn-person\">Emilie Wu<\/span><br \/>\n        <br \/>E-mail:\u00a0<a target=\"_blank\" href=\"mailto:emilie@thepiacentegroup.com\" rel=\"nofollow noopener\">emilie@thepiacentegroup.com<\/a><br \/>Office line: +86 21 6039 8363<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-june-conferences-301300595.html\">http:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-june-conferences-301300595.html<\/a><\/p>\n<p>SOURCE  I-Mab<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CN92247&amp;Transmission_Id=202105270800PR_NEWS_USPR_____CN92247&amp;DateId=20210527\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SHANGHAI and GAITHERSBURG, Md., May 27, 2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in June. Details of the conferences and management presentation are as follows: Jefferies Healthcare Conference (Virtual)Fireside chat: Tuesday, June\u00a01, 2021 at 3:00 p.m.ETSpeaker: Dr. Jingwu Zang, Founder, Chairman and Director Webcast link: https:\/\/wsw.com\/webcast\/jeff174\/imab\/1821663. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. One-on-one meetings: June\u00a02-4, 2021Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Mr. Tianyi Zhang, Executive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;I-Mab Announces Upcoming Participation at June Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499379","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SHANGHAI and GAITHERSBURG, Md., May 27, 2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in June. Details of the conferences and management presentation are as follows: Jefferies Healthcare Conference (Virtual)Fireside chat: Tuesday, June\u00a01, 2021 at 3:00 p.m.ETSpeaker: Dr. Jingwu Zang, Founder, Chairman and Director Webcast link: https:\/\/wsw.com\/webcast\/jeff174\/imab\/1821663. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. One-on-one meetings: June\u00a02-4, 2021Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Mr. Tianyi Zhang, Executive &hellip; Continue reading &quot;I-Mab Announces Upcoming Participation at June Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-27T12:04:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"I-Mab Announces Upcoming Participation at June Conferences\",\"datePublished\":\"2021-05-27T12:04:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/\"},\"wordCount\":621,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN92247&amp;sd=2021-05-27\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/\",\"name\":\"I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN92247&amp;sd=2021-05-27\",\"datePublished\":\"2021-05-27T12:04:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN92247&amp;sd=2021-05-27\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=CN92247&amp;sd=2021-05-27\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/i-mab-announces-upcoming-participation-at-june-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I-Mab Announces Upcoming Participation at June Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/","og_locale":"en_US","og_type":"article","og_title":"I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk","og_description":"PR Newswire SHANGHAI and GAITHERSBURG, Md., May 27, 2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in June. Details of the conferences and management presentation are as follows: Jefferies Healthcare Conference (Virtual)Fireside chat: Tuesday, June\u00a01, 2021 at 3:00 p.m.ETSpeaker: Dr. Jingwu Zang, Founder, Chairman and Director Webcast link: https:\/\/wsw.com\/webcast\/jeff174\/imab\/1821663. The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at http:\/\/ir.i-mabbiopharma.com\/. One-on-one meetings: June\u00a02-4, 2021Management participants: Dr. Jingwu Zang, Founder, Chairman and Director, Dr. Joan Huaqiong Shen, Director and Chief Executive Officer, Mr. Jielun Zhu, Director and Chief Financial Officer, and Mr. Tianyi Zhang, Executive &hellip; Continue reading \"I-Mab Announces Upcoming Participation at June Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-27T12:04:57+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"I-Mab Announces Upcoming Participation at June Conferences","datePublished":"2021-05-27T12:04:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/"},"wordCount":621,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/","name":"I-Mab Announces Upcoming Participation at June Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27","datePublished":"2021-05-27T12:04:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN92247&amp;sd=2021-05-27"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/i-mab-announces-upcoming-participation-at-june-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"I-Mab Announces Upcoming Participation at June Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499379"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499379\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}